7.1 Who May Prescribe in Minnesota

7.1 Who May Prescribe in Minnesota

Quick Answer: Under Minn. Stat. §151.01, subd. 23, a practitioner is a licensed MD/DO (licensed to practice medicine), dentist, optometrist, podiatrist, veterinarian, advanced practice registered nurse (APRN), certified midwife, or physician assistant (PA). Dental therapists and pharmacists are practitioners only for narrow statutory purposes (dispensing/admin limits or protocol-based prescribing under §151.37). Legend-drug prescribing authority lives in §151.37: practitioners prescribe in the course of professional practice; protocol-based orders and telehealth exam rules apply; a pharmacist must not dispense a prescription known (or reasonably expected) to be invalid under the examination rules.

Area 2 of the NABP MPJE blueprint (Pharmacist Practice) weights prescription/drug-order requirements heavily. Before you evaluate drug, quantity, or schedule, you must answer a threshold question: Is the order from someone Minnesota law treats as a lawful prescriber for that drug, for that patient, in that practice setting?

Practitioner Definition — §151.01, subd. 23

Minnesota does not use a casual “any clinician with a DEA number” test for legend-drug authority. The Pharmacy Practice Act defines practitioner as:

• Licensed doctor of medicine
• Licensed doctor of osteopathic medicine duly licensed to practice medicine
• Licensed doctor of dentistry
• Licensed doctor of optometry
• Licensed podiatrist
• Licensed veterinarian
• Licensed advanced practice registered nurse
• Licensed certified midwife
• Licensed physician assistant

Memorize this list as the core roster for ordinary community-pharmacy verification. On exam items, match the title in the stem to this definition before debating refills or labeling.

Limited expansions of “practitioner”

Subdivision 23 also expands “practitioner” only for listed purposes:

1. Dental therapist authorized to dispense and administer under chapter 150A — for purposes including certain sections on dispensing, records, and legend-drug possession under §151.37, subd. 2(b) contexts and related provisions named in the statute.
2. Pharmacist authorized to prescribe under §151.37, subd. 14–17 (self-administered hormonal contraceptives, nicotine replacement, opiate antagonists for acute overdose, and HIV prevention drugs) — for purposes including certain wholesale/dispensing-related sections.

Critical exam nuance: a pharmacist is not a general practitioner who may freely prescribe any legend drug. Pharmacist “practitioner” status is protocol- and category-specific. Full pharmacist prescriptive authority is covered in the advanced-practice chapter; here, remember that protocol prescribing is lawful when the statute’s training, protocol, and age/clinical gates are met.

Legend Drugs: Who May Prescribe — §151.37

Minn. Stat. §151.37, subd. 1 makes it unlawful for any person to possess, sell, give away, barter, exchange, or distribute a legend drug except as the chapter allows. Subdivision 2 then grants the core prescribing power:

A licensed practitioner, in the course of professional practice only, may prescribe, administer, and dispense a legend drug, and may cause administration by a nurse, medical student, or resident under direction and supervision. The practitioner may also cause an appropriately certified, registered, or licensed health care professional to prescribe, dispense, and administer within that person’s expressed legal scope of practice.

Protocol prescribing (standing orders)

Under §151.37, subd. 2(a), a licensed practitioner may prescribe a legend drug without naming a specific patient by directing certain professionals—including a pharmacist according to §151.01, subd. 27—to adhere to a practice guideline or protocol for patients whose condition falls within the protocol, when the protocol specifies when the legend drug is to be prescribed and administered.

An individual who verbally, electronically, or otherwise transmits an order as an agent of a prescriber is not deemed to have prescribed the legend drug. That distinction matters when a nurse or medical assistant “calls in” a refill: the legal prescriber remains the practitioner; the agent is a messenger.

Veterinary practice

§151.37, subd. 3 allows a licensed veterinarian, in the course of professional practice and not for use by a human being, to prescribe, administer, and dispense legend drugs for animals, and to cause administration or dispensing by an assistant under direction and supervision. Human-use prescriptions from veterinarians are a classic invalidity trap.

Scope and “Course of Professional Practice”

Prescriptive authority is always scope-limited:

An out-of-scope order (for example, a dentist prescribing a non-dental chronic cardiology regimen with no dental link) fails the course of professional practice test even if the signature looks perfect.

Examination Rules for High-Risk Drugs — §151.37, subd. 2(d)–(e)

Minnesota adds a validity gate that is highly testable. A prescription drug order for any of the following is not valid unless based on a documented patient evaluation, including an examination, adequate to establish a diagnosis and identify underlying conditions and contraindications:

1. Controlled substances listed in §152.02, subd. 3–5 (Schedules II–IV core listings as cross-referenced)
2. Board-defined controlled substances under §152.02, subd. 7, 8, and 12
3. Muscle relaxants
4. Centrally acting analgesics with opioid activity
5. Drugs containing butalbital
6. Phosphodiesterase type 5 (PDE5) inhibitors when used to treat erectile dysfunction

How the examination requirement is met

Under subd. 2(e), the examination requirement is met if:

(1) An in-person examination has been completed in any of these circumstances:

• The prescribing practitioner examines the patient when the order is issued
• The prescribing practitioner has performed a prior examination of the patient
• Another prescribing practitioner in the same group or clinic examined the patient
• A consulting practitioner to whom the patient was referred examined the patient
• The referring practitioner performed an examination when a consultant issues an order while providing telehealth services

or (2) for PDE5 ED drugs (clause 6) or substance use disorder treatment with medications for opioid use disorder, the prescribing practitioner completed an examination of the patient via telehealth as defined in §62A.673.

Protocol prescribing under subd. 2(a) is not prohibited by these paragraphs (subd. 2(f)). Public-health and pandemic distribution mechanisms also have separate carve-outs (subd. 2(h)).

Pharmacist duty not to dispense invalid orders

§151.37, subd. 2(i)–(j) is the pharmacist’s personal duty:

• No pharmacist working for an in-state Minnesota-licensed pharmacy may dispense a legend drug based on a prescription the pharmacist knows, or would reasonably be expected to know, is not valid under paragraph (d).
• The same standard applies to a pharmacist at an out-of-state pharmacy licensed under §151.19 when dispensing to a Minnesota resident.

“The doctor sent it electronically” does not erase red flags suggesting no adequate exam (internet-only ED clinic with no documented evaluation pathway, cash-only muscle relaxant mill, identical high-dose CS scripts with no clinician relationship). Document clarification attempts; refuse when validity cannot be established.

Out-of-State Prescribers

Minnesota generally recognizes prescriptions from practitioners licensed to prescribe in the state where the prescription is issued, especially for controlled substances under §152.11 when DEA registration and federal content rules are met. Still verify:

• The prescriber type is one Minnesota expects for that drug class
• The order is within usual professional practice
• Federal and Minnesota CS content rules are satisfied
• For high-risk drugs under §151.37, subd. 2(d), examination-based validity is not obviously missing

Worked Verification Sequence

1. Identify prescriber type → match to §151.01, subd. 23 (or limited expansion)
2. Confirm scope and human vs veterinary use
3. Confirm legend vs controlled; if CS, confirm DEA authority for that schedule
4. If the drug is on the subd. 2(d) list, assess examination-based validity and telehealth rules
5. Confirm required prescription content (next section)
6. Only then process quantity, refills, and PMP checks

Common Exam Traps

• Treating every nurse as an independent prescriber (only APRNs with authority; RNs as agents do not “prescribe”)
• Accepting a veterinary prescription for a human patient
• Assuming any electronic order is valid without legitimacy/exam analysis
• Ignoring pharmacist duty under subd. 2(i) when red flags show no exam for a PDE5 ED drug or CS
• Confusing protocol-based pharmacist prescribing with unrestricted MD-level authority

Study Checklist

1. Recite the core practitioner list from §151.01, subd. 23
2. Explain limited dental-therapist and pharmacist expansions
3. State the six high-risk drug categories under §151.37, subd. 2(d)
4. Apply telehealth exam rules under subd. 2(e)
5. Describe the pharmacist’s knows or reasonably should know duty not to dispense invalid orders

Who may prescribe is the first filter of prescription validity. Master the practitioner definition and the examination rules before you argue about signatures, DEA numbers, or refill math.